PRFX PE Ratio & Valuation,Is PRFX Overvalued

PRFX Relative Valuation

PRFX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRFX is overvalued; if below, it's undervalued.

Historical Valuation

PainReform Ltd (PRFX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.10. The fair price of PainReform Ltd (PRFX) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：0.97

Fair

-0.02

0.00

EV/EBITDA

PainReform Ltd. (PRFX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.06

EV/EBIT

PainReform Ltd. (PRFX) has a current EV/EBIT of 0.06. The 5-year average EV/EBIT is -0.03. The thresholds are as follows: Strongly Undervalued below -1.88, Undervalued between -1.88 and -0.95, Fairly Valued between 0.90 and -0.95, Overvalued between 0.90 and 1.83, and Strongly Overvalued above 1.83. The current Forward EV/EBIT of 0.06 falls within the Historic Trend Line -Fairly Valued range.

0.00

PainReform Ltd. (PRFX) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

PainReform Ltd. (PRFX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.09

P/FCF

PainReform Ltd. (PRFX) has a current P/FCF of 0.09. The 5-year average P/FCF is -0.51. The thresholds are as follows: Strongly Undervalued below -2.71, Undervalued between -2.71 and -1.61, Fairly Valued between 0.59 and -1.61, Overvalued between 0.59 and 1.69, and Strongly Overvalued above 1.69. The current Forward P/FCF of 0.09 falls within the Historic Trend Line -Fairly Valued range.

PainReform Ltd (PRFX) has a current Price-to-Book (P/B) ratio of 0.24. Compared to its 3-year average P/B ratio of 1.01 , the current P/B ratio is approximately -76.62% higher. Relative to its 5-year average P/B ratio of 1.06, the current P/B ratio is about -77.72% higher. PainReform Ltd (PRFX) has a Forward Free Cash Flow (FCF) yield of approximately -305.09%. Compared to its 3-year average FCF yield of -375.03%, the current FCF yield is approximately -18.65% lower. Relative to its 5-year average FCF yield of -238.92% , the current FCF yield is about 27.70% lower.

0.24

P/B

Median3y

1.01

Median5y

1.06

-305.09

FCF Yield

Median3y

-375.03

Median5y

-238.92

Competitors Valuation Multiple

The average P/S ratio for PRFX's competitors is 0.03, providing a benchmark for relative valuation. PainReform Ltd Corp (PRFX) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PRFX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PRFX in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PainReform Ltd (PRFX) currently overvalued or undervalued?

What is PainReform Ltd (PRFX) fair value?

PRFX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of PainReform Ltd (PRFX) is between to according to relative valuation methord.

How does PRFX's valuation metrics compare to the industry average?

The average P/S ratio for PRFX's competitors is 0.03, providing a benchmark for relative valuation. PainReform Ltd Corp (PRFX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for PainReform Ltd (PRFX) as of Dec 15 2025?

As of Dec 15 2025, PainReform Ltd (PRFX) has a P/B ratio of 0.24. This indicates that the market values PRFX at 0.24 times its book value.

What is the current FCF Yield for PainReform Ltd (PRFX) as of Dec 15 2025?

As of Dec 15 2025, PainReform Ltd (PRFX) has a FCF Yield of -305.09%. This means that for every dollar of PainReform Ltd’s market capitalization, the company generates -305.09 cents in free cash flow.

What is the current Forward P/E ratio for PainReform Ltd (PRFX) as of Dec 15 2025?

As of Dec 15 2025, PainReform Ltd (PRFX) has a Forward P/E ratio of -0.02. This means the market is willing to pay $-0.02 for every dollar of PainReform Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for PainReform Ltd (PRFX) as of Dec 15 2025?

As of Dec 15 2025, PainReform Ltd (PRFX) has a Forward P/S ratio of 0.00. This means the market is valuing PRFX at $0.00 for every dollar of expected revenue over the next 12 months.

PRFX Valuation

PRFX Valuation

PRFX Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is PainReform Ltd (PRFX) currently overvalued or undervalued?

What is PainReform Ltd (PRFX) fair value?

How does PRFX's valuation metrics compare to the industry average?

What is the current P/B ratio for PainReform Ltd (PRFX) as of Dec 15 2025?

What is the current FCF Yield for PainReform Ltd (PRFX) as of Dec 15 2025?

What is the current Forward P/E ratio for PainReform Ltd (PRFX) as of Dec 15 2025?

What is the current Forward P/S ratio for PainReform Ltd (PRFX) as of Dec 15 2025?